InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Matthew W Foehr, President and CEO, is a corporate insider tracked by InsiderTape across 3 companies. The public record shows 24 open-market SEC Form 4 transactions: 12 purchases worth $8.1M and 12 sales worth $3.8M, reported from Aug 4, 21 to Apr 7, 26. Over this period they have been a mix of buying and selling.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 7, 26 | OABIOmniAb, Inc. | SELL | 19.2K | $1.49 | $29K |
| Feb 18, 26 | OABIOmniAb, Inc. | SELL | 30.8K | $1.71 | $53K |
| Feb 17, 26 | OABIOmniAb, Inc. | SELL | 20.8K | $1.70 | $35K |
| Jan 2, 26 | VKTXViking Therapeutics, Inc. | SELL | 16.0K | $35.11 | $562K |
| Dec 8, 25 | OABIOmniAb, Inc. | SELL | 13.7K | $1.96 | $27K |
| Apr 7, 25 | OABIOmniAb, Inc. | SELL | 19.4K | $2.00 | $39K |
| Feb 19, 25 | OABIOmniAb, Inc. | SELL | 19.5K | $3.67 | $72K |
| Feb 18, 25 | OABIOmniAb, Inc. | SELL | 14.0K | $3.68 | $51K |
| Jan 21, 25 | OABIOmniAb, Inc. | SELL | 41.8K | $3.24 | $135K |
| Dec 9, 24 | OABIOmniAb, Inc. | SELL | 13.6K | $4.13 | $56K |
| May 24, 24 | OABIOmniAb, Inc. | BUY | 240.0K | $4.42 | $1.1M |
| Mar 22, 24 | OABIOmniAb, Inc. | BUY | 225.0K | $5.19 | $1.2M |
| Dec 12, 23 | OABIOmniAb, Inc. | BUY | 200.0K | $5.05 | $1.0M |
| Nov 10, 23 | OABIOmniAb, Inc. | BUY | 95.0K | $4.27 | $406K |
| Aug 14, 23 | OABIOmniAb, Inc. | BUY | 45.0K | $5.48 | $247K |
| Jun 9, 23 | OABIOmniAb, Inc. | BUY | 115.0K | $4.52 | $520K |
| May 12, 23 | OABIOmniAb, Inc. | BUY | 440.0K | $3.40 | $1.5M |
| Dec 12, 22 | OABIOmniAb, Inc. | BUY | 150.0K | $3.77 | $566K |
| Nov 30, 22 | OABIOmniAb, Inc. | BUY | 300.0K | $3.39 | $1.0M |
| Nov 9, 22 | OABIOmniAb, Inc. | BUY | 100.0K | $2.76 | $276K |
| May 13, 22 | LGNDLIGAND PHARMACEUTICALS INC | BUY | 2.5K | $82.76 | $207K |
| May 2, 22 | VKTXViking Therapeutics, Inc. | BUY | 45.0K | $2.47 | $111K |
| Nov 11, 21 | LGNDLIGAND PHARMACEUTICALS INC | SELL | 11.2K | $163.02 | $1.8M |
| Aug 4, 21 | LGNDLIGAND PHARMACEUTICALS INC | SELL | 8.8K | $109.67 | $969K |